John P. Butler, CEO and President: Akebia Therapeutics AKBA Planned sale · Filed 02/02

Trade details

Type: Planned sale notice
Stock: Akebia Therapeutics AKBA
Person: John P. ButlerCEO and President
Planned sale date: 26/02/02
Filed: 26/02/02

0.1% of shares outstanding to be sold

Akebia Therapeutics trades, last 26 weeks

What else happened in Akebia Therapeutics around then

Filed or reported within 30 days of the trade day · 01/03~03/04

John P. Butler's recent trades

John P. ButlerCEO and President
BuyAkebia Therapeutics
Buy
Akebia Therapeutics
AKBA
$86.6K
69,270 sh
$86.6K
Filed 03/05
Traded 03/04
John P. ButlerCEO and President
Sell10b5-1 planAkebia Therapeutics
Sell10b5-1 plan
Akebia Therapeutics
AKBA
$159.7K
114,891 sh
$159.7K
Filed 02/04
Traded 02/02
John P. ButlerCEO and President
Sell10b5-1 planAkebia Therapeutics
Sell10b5-1 plan
Akebia Therapeutics
AKBA
$133.5K
96,065 sh
$133.5K
Filed 02/04
Traded 02/02
John P. ButlerCEO and President
Sell10b5-1 planAkebia Therapeutics
Sell10b5-1 plan
Akebia Therapeutics
AKBA
$116.3K
83,689 sh
$116.3K
Filed 02/04
Traded 02/02
John P. ButlerCEO and President
Sell10b5-1 planAkebia Therapeutics
Sell10b5-1 plan
Akebia Therapeutics
AKBA
$64.9K
46,660 sh
$64.9K
Filed 02/04
Traded 02/02